A detailed history of Clark Capital Management Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 521,318 shares of NVO stock, worth $45.5 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
521,318
Previous 647,102 19.44%
Holding current value
$45.5 Million
Previous $92.4 Million 32.8%
% of portfolio
0.43%
Previous 0.69%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $15 Million - $18.3 Million
-125,784 Reduced 19.44%
521,318 $62.1 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.52 Million - $1.82 Million
12,364 Added 1.95%
647,102 $92.4 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.74 Million - $2.32 Million
17,085 Added 2.77%
634,738 $81.5 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2.02 Million - $2.42 Million
22,995 Added 3.87%
617,653 $63.9 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $27.9 Million - $61.1 Million
306,404 Added 106.3%
594,658 $54.1 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $1.71 Million - $1.89 Million
10,966 Added 3.95%
288,254 $46.6 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $919,763 - $1.11 Million
6,950 Added 2.57%
277,288 $44.1 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $838,141 - $1.11 Million
8,173 Added 3.12%
270,338 $36.6 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $722,127 - $886,212
7,579 Added 2.98%
262,165 $26.1 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $1.42 Million - $1.68 Million
13,775 Added 5.72%
254,586 $28.4 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $22.1 Million - $26.7 Million
237,562 Added 7311.85%
240,811 $26.7 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $27.7 Million - $33.8 Million
-288,846 Reduced 98.89%
3,249 $364,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $1.04 Million - $1.31 Million
12,311 Added 4.4%
292,095 $28 Million
Q2 2021

Aug 02, 2021

BUY
$67.66 - $84.76 $18.9 Million - $23.7 Million
279,784 New
279,784 $23.4 Million
Q4 2017

Feb 14, 2018

SELL
$47.53 - $53.73 $7.44 Million - $8.41 Million
-156,568 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $6.44 Million - $7.71 Million
156,568
156,568 $7.54 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.